Infection of human dendritic cells by dengue virus activates and primes T cells towards TH0-like phenotype producing both TH1 and TH2 cytokines

Immunological Investigations

Volumn 33, Issue 4, 2004, Pages 423-437

  Ho, Ling Jun ^a   Shaio, Men Fang ^b   Chang, Deh Ming ^c   Liao, Ching Len ^d   Lai, Jenn Haung ^c  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b Dept of Parasitol and Trop Med ^*  (Taiwan)

^c TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^d NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

Cytokines; Dendritic cells; Dengue viruses; T cells; T helper 1 T helper 2

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4;

ARTICLE; CELL INTERACTION; CELL PROLIFERATION; CONTROLLED STUDY; DENDRITIC CELL; DENGUE; DENGUE VIRUS; HUMAN; HUMAN CELL; IMMUNE SYSTEM; LYMPHOID TISSUE; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE; TH1 CELL; TH2 CELL; ULTRAVIOLET RADIATION; VIRUS PATHOGENESIS;

CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; CYTOKINES; DENDRITIC CELLS; DENGUE VIRUS; FLAVIVIRUS INFECTIONS; HUMANS; LYMPHOCYTE ACTIVATION; PHENOTYPE; T-LYMPHOCYTES, HELPER-INDUCER; TH1 CELLS; TH2 CELLS;

EID: 9744257982     PISSN: 08820139     EISSN: None     Source Type: Journal    
DOI: 10.1081/IMM-200038680     Document Type: Article

References (37)

1. Avirutnan, P., Malasit, P., Seliger, B., Bhakdi, S., Husmann, M. (1998). Dengue virus infection of human endothelial cells leads to chemokine production, complement activation, and apoptosis. J. Immunol. 161:6338-6346.
2. Banchereau, J., Steinman, R. M. (1998). Dendritic cells and the control of immunity. Nature 392:245-252.
3. Banchereau, J., Briere, F., Caux, C., Davoust, J., Lebecque, S., Liu, Y. J., Pulendran, B., Palucka, K. (2000). Immunobiology of dendritic cells. Annu. Rev. Immunol. 18:767-811.
4. Bethell, D. B., Flobbe, K., Cao, X. T., Day, N. P., Pham, T. P., Buurman, W. A., Cardosa, M. J., White, N. J., Kwiatkowski, D. (1998). Pathophysiologic and prognostic role of cytokines in dengue hemorrhagic fever. J. Infect. Dis. 177:778-782.
5. + T cells. J. Immunol. 166:5250-5257.
6. Cella, M., Facchetti, F., Lanzavecchia, A., Colonna, M. (2000). Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization. Nat. Immunol. 1:305-310.
7. Chaturvedi, U. C., Elbishbishi, E. A., Agarwal, R., Raghupathy, R., Nagar, R., Tandon, R., Pacsa, A. S., Younis, O. I., Azizieh, F. (1999). Sequential production of cytokines by dengue virus-infected human peripheral blood leukocyte cultures. J. Med. Virol. 59:335-340.
8. + T cell responses: the alternative approaches. Annu. Rev. Immunol. 15:297-322.
9. da Fonseca, B. A., Fonseca, S. N. (2002). Dengue virus infections. Curr. Opin. Pediatr. 14:67-71.
10. Engelmayer, J., Larsson, M., Subklewe, M., Chahroudi, A., Cox, W. I., Steinman, R. M., Bhardwaj, N. (1999). Vaccinia virus inhibits the maturation of human dendritic cells: a novel mechanism of immune evasion. J. Immunol. 163:6762-6768.
11. Green, S., Vaughn, D. W., Kalayanarooj, S., Nimmannitya, S., Suntayakorn, S., Nisalak, A., Lew, R., Innis, B. L., Kurane, I., Rothman, A. L., Ennis, F. A. (1999a). Early immune activation in acute dengue illness is related to development of plasma leakage and disease severity. J. Infect. Dis. 179:755-762.
12. Green, S., Vaughn, D. W., Kalayanarooj, S., Nimmannitya, S., Suntayakorn, S., Nisalak, A., Rothman, A. L., Ennis, F. A. (1999b). Elevated plasma interleukin-10 levels in acute dengue correlate with disease severity. J. Med. Virol. 59:329-334.
13. + T cells. J. Exp. Med. 186:801-812.
14. Gubler, D. J. (1998). Dengue and dengue hemorrhagic fever. Clin. Microbiol. Rev. 11:480-496.
15. Ho, L. J., Wang, J. J., Shaio, M. F., Kao, C. L., Chang, D. M., Han, S. W., Lai, J. H. (2001a). Infection of human dendritic cells by Dengue virus causes cell maturation and cytokine production. J. Immunol. 166:1499-1506.
16. Ho, L. J., Chang, D. M., Shiau, H. Y., Chen, C. H., Hsieh, T. Y., Hsu, Y. L., Wong, C. S., Lai, J. H. (2001b). Aspirin differentially regulates endotoxin-induced IL-12 and TNF-α production in human dendritic cells. Scand. J. Rheumatol. 30:346-352.
17. + T helper cell phenotype development in a T cell receptor-alpha beta-transgenic model. J. Exp. Med. 182:1579-1584.
18. Iezzi, G., Scotet, E., Scheidegger, D., Lanzavecchia, A. (1999). The interplay between the duration of TCR and cytokine signaling determines T cell polarization. Eur. J. Immunol. 29:4092-4101.
19. Kanto, T., Hayashi, N., Takehara, T., Tatsumi, T., Kuzushita, N., Ito, A., Sasaki, Y., Kasahara, A., Hori, M. (1999). Impaired allostimulatory capacity of peripheral blood dendritic cells recovered from hepatitis C virus-infected individuals. J. Immunol. 162:5584-5591.
20. Knight, S. C., Iqball, S., Roberts, M. S., Macatonia, S., Bedford, P. A. (1998). Transfer of antigen between dendritic cells in the stimulation of primary T cell proliferation. Eur. J. Immunol. 28:1636-1644.
21. Koraka, P., Suharti, C., Setiati, T. E., Mairuhu, A. T., Van Gorp, E., Hack, C. E., Juffrie, M., Sutaryo, J., Van Der Meer, G. M., Groen, J., Osterhaus, A. D. (2001). Kinetics of dengue virus-specific serum immunoglobulin classes and subclasses correlate with clinical outcome of infection. J. Clin. Microbiol. 39:4332-4338.
22. Kruse, M., Rosorius, O., Kratzer, F., Stelz, G., Kuhnt, C., Schuler, G., Hauber, J., Steinkasserer, A. (2000). Mature dendritic cells infected with herpes simplex virus type 1 exhibit inhibited T-cell stimulatory capacity. J. Virol. 74:7127-7136.
23. Kuchroo, V. K., Das, M. P., Brown, J. A., Ranger, A. M., Zamvil, S. S., Sobel, R. A., Weiner, H. L., Nabavi, N., Glimcher, L. H. (1995). B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 80:707-718.
24. Kurane, I., Innis, B. L., Nimmannitya, S., Nisalak, A., Meager, A., Janus, J., Ennis, F. A. (1991). Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CDS, interleukin 2, and interferon-gamma in sera of children with dengue. J. Clin. Invest. 88:1473-1480.
25. Kurane, I., Innis, B. L., Hoke, C. H. Jr., Eckels, K. H., Meager, A., Janus, J., Ennis, F. A. (1995). T cell activation in vivo by dengue virus infection. J. Clin. Lab. Immunol. 46:35-40.
26. Lai, J. H., Ho, L. J., Kwan, C. Y., Chang, D. M., Lee, T. C. (1999). Plant alkaloid tetrandrine and its analog block CD28-costimulated activities of human peripheral blood T cells: potential immunosuppressants in transplantation immunology. Transplantation 68:1383-1392.
27. Lai, J. H., Ho, L. J., Lu, K. C., Chang, D. M., Shaio, M. F., Han, S. H. (2001). Western and Chinese antirheumatic drug-induced T cell apoptotic DNA damage uses different caspase cascades and is independent of Fas/Fas ligand interaction. J. Immunol. 166:6914-6924.
28. Langenkamp, A., Messi, M., Lanzavecchia, A., Sallusto, F. (2000). Kinetics of dendritic cell activation: impact on priming of TH1, TH2 and nonpolarized T cells. Nat. Immunol. 1:311-316.
29. Lei, H. Y., Yeh, T. M., Liu, H. S., Lin, Y. S., Chen, S. H., Liu, C. C. (2001). Immunopathogenesis of dengue virus infection. J. Biomed. Sci. 8:377-388.
30. Mathew, A., Kurane, I., Green, S., Vaughn, D. W., Kalayanarooj, S., Suntayakorn, S., Ennis, F. A., Rothman, A. L. (1999). Impaired T cell proliferation in acute dengue infection. J. Immunol 162:5609-5615.
31. Oh, S., Eichelberger, M. C. (2000). Polarization of allogeneic T-cell responses by influenza virus-infected dendritic cells. J. Virol. 74:7738-7744.
32. Rothman, A. L. (2003). Immunology and immunopathogenesis of dengue disease. Adv. Virus Res. 60:397-419.
33. Schnorr, J. J., Xanthakos, S., Keikavoussi, P., Kampgen, E., ter Meulen, V., Schneider-Schaulies, S. (1997). Induction of maturation of human blood dendritic cell precursors by measles virus is associated with immunosuppression. Proc. Natl. Acad. Sci. U. S. A. 94:5326-5331.
34. Steinbach, F., Borchers, K., Ricciardi-Castagnoli, P., Ludwig, H., Stingl, G., Elbe-Burger, A. (1998). Dendritic cells presenting equine herpesvirus-1 antigens induce protective anti-viral immunity. J. Gen. Virol. 79:3005-3014.
35. Tassaneetrithep, B., Burgess, T. H., Granelli-Piperno, A., Trumpfheller, C., Finke, J., Sun, W., Eller, M. A., Pattanapanyasat, K., Sarasombath, S., Birx, D. L., Steinman, R. M., Schlesinger, S., Marovich, M. A. (2003). DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells. J. Exp. Med. 197:823-829.
36. Vaughn, D. W., Green, S., Kalayanarooj, S., Innis, B. L., Nimmannitya, S., Suntayakorn, S., Rothman, A. L., Ennis, F. A., Nisalak, A. (1997). Dengue in the early febrile phase: viremia and antibody responses. J. Infect. Dis. 176:322-330.
37. Wu, S.-J. L., Grouard-Vogel, G., Sun, W., Mascola, J. R., Brachtel, E., Putvatana, R., Louder, M. K., Filgueira, L., Marovich, M. A., Wong, H. K., Blauvelt, A., Murphy, G. S., Robb, M. L., Innes, B. L., Birx, D. L., Hayes, C. G., Frankel, S. S. (2000). Human skin Langerhans cells are targets of dengue virus infection. Nat. Med. 6:816-820.